当前位置:首页 - 行情中心 - 迈瑞医疗(300760) - 财务分析 - 现金流量表

迈瑞医疗

(300760)

  

流通市值:2733.98亿  总市值:2734.06亿
流通股本:12.12亿   总股本:12.12亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金17,718,258,4868,732,237,37440,142,581,62931,577,572,788
  收到的税费返还480,675,210250,579,8071,005,531,131866,820,743
  收到其他与经营活动有关的现金610,951,976453,341,538800,729,404616,673,890
  经营活动现金流入小计18,809,885,6729,436,158,71941,948,842,16433,061,067,421
  购买商品、接受劳务支付的现金6,552,579,9543,146,581,72014,685,533,87510,379,652,537
  支付给职工以及为职工支付的现金5,187,333,1303,400,100,5688,118,905,8906,428,507,799
  支付的各项税费1,724,908,027752,899,7424,298,552,1473,297,688,701
  支付其他与经营活动有关的现金1,422,972,360642,168,6322,413,808,9711,882,337,388
  经营活动现金流出小计14,887,793,4717,941,750,66229,516,800,88321,988,186,425
  经营活动产生的现金流量净额3,922,092,2011,494,408,05712,432,041,28111,072,880,996
二、投资活动产生的现金流量:
  收回投资收到的现金1,259,678,764744,600,0001,323,911,149592,800,000
  取得投资收益收到的现金2,998,7831,566,2785,360,9012,799,041
  处置固定资产、无形资产和其他长期资产收回的现金净额33,475,2282,876,37930,736,11514,757,134
  收到的其他与投资活动有关的现金1,673,957,323-141,535,123141,245,072
  投资活动现金流入小计2,970,110,098749,042,6571,501,543,288751,601,247
  购建固定资产、无形资产和其他长期资产支付的现金1,016,735,002497,382,5771,959,448,2541,417,824,137
  投资支付的现金1,322,000,000685,000,0001,112,301,559730,696,848
  取得子公司及其他营业单位支付的现金--5,773,292,2745,773,292,274
  支付其他与投资活动有关的现金--39,712,00039,712,000
  投资活动现金流出小计2,338,735,0021,182,382,5778,884,754,0877,961,525,259
  投资活动产生的现金流量净额631,375,096-433,339,920-7,383,210,799-7,209,924,012
三、筹资活动产生的现金流量:
  吸收投资收到的现金20,873,979-78,533,52469,759,005
  其中:子公司吸收少数股东投资收到的现金20,873,979-78,533,52469,759,005
  取得借款收到的现金4,174,70752,0722,643,4102,412,327
  收到其他与筹资活动有关的现金81,219,896-50,545,87538,036,327
  筹资活动现金流入小计106,268,58252,072131,722,809110,207,659
  偿还债务支付的现金1,187,903685,9225,500,3585,112,257
  分配股利、利润或偿付利息支付的现金2,517,197,653161,3728,843,406,8466,842,338,528
  其中:子公司支付给少数股东的股利、利润128,432,964-100,905,212100,905,212
  支付其他与筹资活动有关的现金197,053,29429,455,976164,529,004121,538,578
  筹资活动现金流出小计2,715,438,85030,303,2709,013,436,2086,968,989,363
  筹资活动产生的现金流量净额-2,609,170,268-30,251,198-8,881,713,399-6,858,781,704
四、汇率变动对现金及现金等价物的影响35,771,92816,298,89972,189,446-89,628,681
五、现金及现金等价物净增加额1,980,068,9571,047,115,838-3,760,693,471-3,085,453,401
  加:期初现金及现金等价物余额14,907,725,80714,907,725,80718,668,419,27818,668,419,278
  期末现金及现金等价物余额16,887,794,76415,954,841,64514,907,725,80715,582,965,877
补充资料:
  净利润5,232,692,188-11,739,966,642-
  资产减值准备229,499,991-237,841,474-
  固定资产和投资性房地产折旧354,386,442-625,926,899-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧354,386,442-624,042,336-
    投资性房地产折旧--1,884,563-
  无形资产摊销423,485,850-712,662,325-
  长期待摊费用摊销12,475,921-34,417,151-
  递延收益摊销---37,903,465-
  处置固定资产、无形资产和其他长期资产的损失-736,574--4,243,844-
  公允价值变动损失-250,473--126,027,776-
  财务费用-133,460,180-97,399,220-
  投资损失-100,922,057--69,390,139-
  递延所得税163,130,039--440,236,450-
  其中:递延所得税资产减少182,611,984--373,672,224-
    递延所得税负债增加-19,481,945--66,564,226-
  存货的减少-599,783,982--782,046,572-
  经营性应收项目的减少-596,037,314--347,146,870-
  经营性应付项目的增加-1,006,694,280-402,206,123-
  其他-127,200,036---
  不涉及现金收支的投资和筹资活动金额其他项目--79,576,430-
  现金的期末余额16,887,794,764-14,907,725,807-
  减:现金的期初余额14,907,725,807-18,668,419,278-
  现金及现金等价物的净增加额1,980,068,957--3,760,693,471-
公告日期2025-08-282025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑